PRESS STATEMENTS

05.21.2015

Pfizer Applauds the Committee on Energy and Commerce for Passing the 21st Century Cures Act Today

04.30.2015

Pfizer Praises Passage Of New Alabama Legislation

10.16.2014

Statement Regarding FDA Advisory Committees’ Vote on CHANTIX®

05.07.2014

The Benefits of a Potential Combination with AstraZeneca PLC ("AstraZeneca")

02.06.2014

U.S. Appeals Court Upholds Lyrica Patent That Expires On December 30, 2018

10.07.2013

Bridget Walsh Appointed Vice President of Federal Government Relations

09.25.2013

Pfizer subsidiary Meridian awarded government contract to develop auto-injector medical countermeasure against nerve agent exposure

07.24.2013

Pfizer Statement on PhRMA-EFPIA Principles for Responsible Clinical Trial Data Sharing

07.02.2013

Pfizer Mourns Loss of Prominent Leader and Respected Board Member

03.19.2013

Pfizer Responds to New York Times Article on NIH Policy

03.18.2013

Original Statement Provided to New York Times

03.15.2013

Pfizer Response To Global Consensus Statement On Menopausal Hormone Therapy

03.12.2013

Zithromax (azithromycin) FDA Drug Safety Communication

11.29.2012

Pfizer Chairman and Chief Executive Officer Ian Read Issues Statement on White House Meeting

10.24.2012

Pfizer Donates Vials of Factor IX to the World Federation of Hemophilia to Help Developing Countries

10.03.2012

Findings from the Kronos Early Estrogen Prevention Study (KEEPS), presented today at The North American Menopause Society (NAMS) Annual Meeting in Orlando, Fla.

08.30.2012

The U.S. Food and Drug Administration issued a Drug Safety Communication on Revatio®

07.30.2012

Pfizer Helpful Answers mourns the loss of actor Lupe Ontiveros

07.09.2012

Ongoing Analyses have Helped Re-evaluate Benefit-Risk Profile of Hormone Therapy for Appropriate Menopausal Women

03.15.2012

Pfizer Response To Ongoing Evaluation Of Hormone Therapy And Breast Cancer, And What It Means For Menopausal Women Who Have Had A Hysterectomy